| Date | Title | Description | Source |
| 29.04.2024 | WuXi AppTec Achieved First Quarter 2024 Target Despite Exter... | Revenue Reached RMB7,982 Million; Excluding COVID-19 Commercial Projects, Down 1.8%
Net Profit Attri... | en.prnasia... |
| 18.03.2024 | WuXi AppTec Revenue Surpassed RMB40 Billion in 2023, and Adj... | Revenue Up 2.5% Year-over-Year to RMB40,341 Million; Excluding COVID-19 Commercial Projects, Up 25.6... | en.prnasia... |
| 12.03.2024 | Drug Discovery Market Size, Share And Growth Analysis For 20... | Drug Discovery Global Market Report 2024 – Market Size, Trends, And Forecast 2024-2033
The Business ... | einpresswi... |
| 06.03.2024 | US Senate Debates Bill Targeting Chinese Biotech Giants WuXi... | Quincy Jon, Tech Times 06 March 2024, 08:03 am
In a significant development on Capitol Hill, a groun... | techtimes.... |
| 04.03.2024 | Pharmaceutical Manufacturing Market Projected to Grow at 7.8... | Vantage Market Research
Pharmaceutical Manufacturing Market Size, Share, Industry Trends, Growth, an... | einpresswi... |
| 20.02.2024 | WuXi Advanced Therapies Receives FDA Approval to Manufacture... | AMTAGVI is the first and only one-time, individualized T cell therapy to receive U.S. FDA approval f... | en.prnasia... |
| 30.10.2023 | WuXi AppTec Continued Solid Growth in the First Three Quarte... | Revenue of RMB10,670 Million in the Third Quarter, Single Quarter Revenue Back to over RMB10 Billion... | en.prnasia... |
| 31.07.2023 | WuXi AppTec Announced Strong Results of the Second Quarter a... | Revenue of RMB9,908 Million in the Second Quarter, Up 6.7% Year-over-Year;
Excluding COVID-19 Commer... | en.prnasia... |
| 24.04.2023 | WuXi AppTec Continued Solid Growth in First-Quarter of 2023 ... | Revenue Up 5.8% Year-Over-Year to RMB8,964 Million
Net Profit Attributable to Owners of the Company ... | en.prnasia... |
| 16.02.2023 | WuXi AppTec Named "Industry Mover" in S&P Glob... | SHANGHAI, Feb. 16, 2023 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfoli... | en.prnasia... |
| 21.12.2022 | WuXi AppTec Named to the 2022 Dow Jones Sustainability World... | SHANGHAI, Dec. 21, 2022 /PRNewswire/ -- WuXi AppTec, a leading global provider of R&D and manufa... | en.prnasia... |
| 21.12.2022 | WuXi AppTec Named to the 2022 Dow Jones Sustainability World... | SHANGHAI, Dec. 20, 2022 /PRNewswire/ -- WuXi AppTec, a leading global provider of R&D and manufa... | einpresswi... |
| 26.10.2022 | WuXi AppTec Reports Record Year-to-Date Results in 2022, Thi... | Revenue Up 71.9% Year-Over-Year to RMB28,395 Million
Net Profit Attributable to Owners of the Compan... | en.prnasia... |
| 14.10.2022 | Will the Taiwan Semiconductor Manufacturing Company of Drugs... | On Aug. 25, President Biden signed the monumental $52.7 billion CHIPS and Science Act into law. The ... | lawfareblo... |
| 17.08.2022 | WuXi STA Breaks Ground for New Pharmaceutical Manufacturing ... | MIDDLETOWN, Del., Aug. 17, 2022 /PRNewswire/ -- WuXi STA, a leading Contract Research, Development, ... | en.prnasia... |
| 12.08.2022 | WuXi ATU Announces Licensing Agreement with Janssen for TESS... | PHILADELPHIA, Aug. 12, 2022 /PRNewswire/ -- WuXi Advanced Therapies (WuXi ATU), a wholly owned subsi... | en.prnasia... |
| 19.07.2022 | WuXi AppTec Plans to Build a New Site in Singapore, Better S... | SINGAPORE, July 19, 2022 /PRNewswire/ -- WuXi AppTec, a leading global provider of R&D and manuf... | en.prnasia... |
| 16.06.2022 | WuXi ATU and Wugen Announce Manufacturing Partnership to Exp... | PHILADELPHIA and ST. LOUIS, MO and SAN DIEGO, June 16, 2022 /PRNewswire/ -- WuXi Advanced Therapies ... | en.prnasia... |
| 25.04.2022 | WuXi AppTec Reports Record First-Quarter In 2022 | Revenue Up 71.2% Year-Over-Year to RMB8,474 Million
Net Profit Attributable to Owners of the Company... | en.prnasia... |
| 08.04.2022 | WuXi AppTec Recognized as Top-Rated ESG Company by Sustainal... | SHANGHAI, April 8, 2022 /PRNewswire/ -- WuXi AppTec, a leading global provider of R&D and manufa... | en.prnasia... |
| 09.12.2021 | WuXi AppTec Receives 2021 Global Customer Value Leadership A... | SHANGHAI, Dec. 9, 2021 /PRNewswire/ -- WuXi AppTec, a leading global provider of R&D and manufac... | en.prnasia... |
| 29.10.2021 | WuXi AppTec Reports Strong Third-Quarter 2021 Results | WuXi AppTec Reports Strong Third-Quarter 2021 Results
2021/10/29
Revenue Up 30.6% Year-Over-Year to ... | marketscre... |
| 18.10.2021 | WuXi ATU Opens New Manufacturing Facility to Further Enhance... | PHILADELPHIA, Oct. 18, 2021 /PRNewswire/ -- WuXi Advanced Therapies Inc. (WuXi ATU) – a wholly owned... | en.prnasia... |
| 06.09.2021 | WuXi AppTec : Receives AA ESG Rating from MSCI | SHANGHAI, Sept. 5, 2021 /PRNewswire/ -- WuXi AppTec ("the Company") is pleased to announce... | marketscre... |
| 06.09.2021 | WuXi AppTec Receives AA ESG Rating from MSCI | SHANGHAI, Sept. 6, 2021 /PRNewswire/ -- WuXi AppTec ("the Company") is pleased to announce... | en.prnasia... |
| 12.08.2021 | WuXi AppTec Reports Strong 2021 Interim Results | Revenue Up 45.7% Year-Over-Year to RMB10,537 Million
Net Profit Attributable to Owners of the Compan... | en.prnasia... |
| 29.06.2021 | WuXi AppTec-backer Eight Roads launches $400m healthcare fun... | Eight Roads, a global investment firm backed by US global financial services giant Fidelity Investme... | dealstreet... |
| 29.06.2021 | WuXi AppTec-backer Eight Roads launches $400m healthcare fun... | Premium
Eight Roads, a global investment firm backed by US global financial services giant Fidelity ... | dealstreet... |
| 24.02.2021 | WuXi Diagnostics Secures US$150M in Series B Financing | WuXi Diagnostic Investment (Cayman) Limited, a Shangai, China-based diagnostics company, completed U... | finsmes.co... |
| 24.02.2021 | Chinese diagnostics firm WuXi Diagnostics raises $150m in Se... | Premium
Chinese integrated diagnostics developer WuXi Diagnostics has raised $150 million in a Serie... | dealstreet... |
| 24.02.2021 | Chinese diagnostics firm WuXi Diagnostics raises $150m in Se... | Chinese integrated diagnostics developer WuXi Diagnostics has raised $150 million in a Series B roun... | dealstreet... |
| 18.11.2020 | Wuxi Biortus Biosciences Raises US$15M in Series A Financing | Wuxi Biortus Biosciences Co. Ltd., a Wuxi, China-based leader in structural biology service for drug... | finsmes.co... |
| 19.02.2020 | General Atlantic, WuXi AppTec lead $98m Series D in CANbridg... | Premium
CANbridge Pharmaceutical Inc that is focused on rare disease therapies has raised $98 millio... | dealstreet... |
| 10.12.2018 | WuXi AppTec starts a global wave of expansion, jumping o... | As WuXi AppTec reportedly raises $1 billion from its public listing in Hong Kong donning a v... | endpts.com... |
| 28.11.2018 | Temasek-backed genomics firm Wuxi NextCODE raises $200m | Premium
WuXi NextCODE, the Temasek-backed Chinese genomics startup, has raised $200 million in a Ser... | dealstreet... |
| 28.11.2018 | Chinese medical tech platform WuXi AppTec launches $1 billio... | By Julia Fioretti
3 Min Read
HONG KONG (Reuters) - Shanghai-listed Chinese medical tech platform WuX... | reuters.co... |
| 27.11.2018 | Global syndicate backs $400M genomics R&D play in Ir... | The big push to translate fresh mounds of genomics data into new meds got a significant boost... | endpts.com... |
| 11.06.2018 | With strategic investment, Insilico Medicine is using deep l... | Every once in a while, you meet an entrepreneur who is both fully present, but also has a head full ... | techcrunch... |
| 08.05.2018 | China Digest: Wuxi Vision nabs $12.6m from Qiming, Ruijian; ... | Premium
In the latest startup financing, Wuxi Vision Pro Ltd., an ophthalmic medical device maker, h... | dealstreet... |
| 08.05.2018 | Listing in Shanghai, WuXi AppTec raises a $354M IPO for C... | One day after Hong Kong’s stock exchange scored its first pre-revenue IPO application, Shangh... | endpts.com... |
| 07.05.2018 | Wuxi Vision raises $13M to commercialize cataract devices | Wuxi Vision Pro has raised $13 million to advance its intraocular lens business. The Chinese medical... | fiercebiot... |
| 28.03.2018 | Global CRO WuXi AppTec looks to raise $900M-plus from Shang... | → Ge Li’s WuXi AppTec has filed for an IPO in Shanghai that’s expected to haul in more than $900 ... | endpts.com... |
| 08.03.2018 | Juno, WuXi JV gets a $90M round as China’s CAR-T pioneers... | Hans Bishop
Close to two years after Hans Bishop at Juno and Ge Li at WuXi AppTec joined hands on... | endpts.com... |
| 25.01.2018 | Fast-growing Shanghai Pharma to plant foot in San Diego, ... | A multi-billion dollar Chinese pharma conglomerate, blessed with municipal government b... | endpts.com... |
| 07.09.2017 | Genomics firm WuXi NextCODE raises $240m from Sequoia China,... | Premium
A Temasek-backed genomics firm has raised $240 million in its latest funding round from a co... | dealstreet... |
| 03.05.2017 | Amgen backs WuXi NextCODE’s $75M B round; ImCheck bags €20... | → The global contract genomics outfit WuXi NextCODE raised a $75 million B round from an inter... | endpts.com... |
| 15.12.2015 | WuXi Healthcare Ventures Closes $290M Fund | Chinese life sciences and healthcare venture capital firm WuXi Healthcare Ventures closed its $290m ... | finsmes.co... |
| 18.11.2015 | Temasek, Hillhouse Capital invest $150m in Chinese home list... | Premium
Shangai-based Aiwujiwu, a Chinese rental and second-home listings portal, has completed a Se... | dealstreet... |
| 14.07.2015 | WuXi launches $250M fund to invest in life sciences startups | We own 100% of this fund, to which we have made a capital funding commitment of up to $50 million, w... | medcitynew... |
| 09.01.2014 | Avelas’ luminous mapping technology to guide breast cancer s... | Avalon Ventures led the round and new investors Torrey Pines Investment, WuXi AppTec and an unnamed ... | medcitynew... |
| 13.08.2013 | WuXi Pharma Tech Raises Q3 Guidance; Jefferies Raise Price T... | Chinese contract research organization (CRO) WuXi Pharma Tech (WX) reported a strong Q2 and raised Q... | blogs.barr... |
| 24.08.2012 | Novira Therapeutics Secures $23M in Series A Financing | Novira Therapeutics Inc., a Radnor, PA-based antiviral drug discovery company, has secured $23m in S... | finsmes.co... |
| 24.08.2012 | Novira Therapeutics raises $23M for hepatitis B treatment th... | Osvaldo (Lalo) Flores, the president and chief scientific officer of Novira Therapeutics in Radnor, ... | medcitynew... |
| 26.04.2010 | Charles River Labs to pay $1.6 billion for WuXi PharmaTech | Charles River Laboratories International Inc. (NYSE:CRL) didn’t let disappointing first-quarter resu... | massdevice... |
| - | Avelas’ luminous mapping technology to guide breast cancer s... | The development of ways to illuminate cancerous tissue to guide surgeons is a life science innovatio... | medcitynew... |
| - | WuXi launches $250M fund to invest in life sciences startups | —The venture arm of China-based R&D powerhouse WuXi PharmaTech is raising its second venture fun... | medcitynew... |
| - | Novira Therapeutics raises $23M for hepatitis B treatment th... | A biotechnology company with a novel drug treatment for hepatitis B and HIV patients could change th... | medcitynew... |
